TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $543,739 | +526.5% | 172,069 | +31.0% | 0.00% | – |
| Q2 2023 | $86,794 | +23.9% | 131,308 | +49.5% | 0.00% | – |
| Q1 2023 | $70,039 | +31.3% | 87,813 | +272.0% | 0.00% | – |
| Q4 2022 | $53,352 | +11.2% | 23,607 | -5.4% | 0.00% | – |
| Q3 2022 | $48,000 | -81.9% | 24,962 | -65.2% | 0.00% | – |
| Q2 2022 | $265,000 | -76.9% | 71,651 | -59.2% | 0.00% | – |
| Q1 2022 | $1,148,000 | -30.8% | 175,755 | +23.5% | 0.00% | – |
| Q4 2021 | $1,658,000 | -28.8% | 142,345 | +13.8% | 0.00% | – |
| Q3 2021 | $2,328,000 | +203.9% | 125,094 | +246.4% | 0.00% | – |
| Q2 2021 | $766,000 | +64.4% | 36,110 | +57.3% | 0.00% | – |
| Q1 2021 | $466,000 | -44.0% | 22,961 | -26.7% | 0.00% | – |
| Q4 2020 | $832,000 | – | 31,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |